Mayo Clinic (Arizona)
Phoenix, AZ
Accepting patients
Q702
MC220806: Phase I Study Evaluating the Efficacy of CSF1R and TAM Receptor or Inhibition in Hematologic Malignancies With Q702, a Small Molecular Inhibitor
- CSF1R Inhibitor
- MER Inhibitor
- Tyrosine Kinase (TK) Inhibitor
- AXL Inhibitor
- Phase 1
Accepting patients
MyeloMATCH Master Protocol
Master Screening and Reassessment Protocol (MSRP) for the NCI MyeloMATCH Clinical Trials
- Genetic Sequencing
- Phase 2
Accepting patients
Phase 1/2 Multicenter, Open-Label Study of CTX-712 in Patients With Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- CLK Inhibitor
- Phase 1/2
Accepting patients
Bone Marrow Failure Clinic Study
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
- Observational Trial